image image
Our Mission

History of BABES

BABES Snapshots

Newly Diagnosed?

"BABES Talking" Newsletter

Order the Newsletter

BABES Perspective

Memorial

Meet the Staff

Meet the Board

Upcoming Events

Local Resources

Links

Job Openings

Want to Volunteer?

Donate

Thank You

HOME
image


image
image image
image
Babes Perspective
image
image
image

Sustiva
The New Pill on the Block
New drug offers alternative to Protease Inhibitors

Crix Belly, buffalo humps, dangerous levels of fat in the blood, and breast increases are the price many women are paying to fight HIV with Protease Inhibitors. What’s a woman to do? One option is to start a group of drugs that does not include a protease inhibitor, also known as protease sparing regimens. A drug recently approved by the FDA which could be used in one of these regimens is called SUSTIVA (efavirenz or DMP-266) and is sold by DuPont Pharma.

Does it work?
The simple answer is yes, Sustiva has been shown in early studies to reduce viral load and increase CD4 cell counts. The most commonly referred to study is the DuPont study 006 comparing the combinations of AZT + 3TC + Sustiva to AZT + 3TC + Crixivan to Sustiva + Crixivan. This study looked at 450 people of which 67 (14%) were women. The 74% of people who took Sustiva had their viral loads go to below the level of detection (400 copies m/l). The people in this study had only been on Sustiva for 36 weeks so it is impossible to say if Sustiva will have a long-term effect for people living with HIV /AIDS.

Sustiva and Oral Contraceptives
DuPont has not been able to study Sustiva's impact on all available oral contraceptives. Until there is more information, women should not use oral contraceptives alone when taking Sustiva, a barrier contraceptive should also be used. It is important to prevent accidental pregnancy when using Sustiva because of the risk of birth defects.

Pregnancy and Sustiva
Pregnancy and Sustiva don’t mix. DuPont studied Sustiva in pregnant monkeys giving them Sustiva throughout their pregnancy. Three of the 20 pregnancies resulted in serious birth defects that were attributed to the mother taking Sustiva. Based on this study, it is suggested that any woman who has sex with men and is considering starting Sustiva should have a pregnancy test first and should use a birth control method other than an oral contraceptive (i.e. "male" or "female" condoms, diaphragm, etc.). If you know you are pregnant or are considering getting pregnant you should not use Sustiva.

SUSTIVA SIDE EFFECTS:
Sustiva is easy to take but there are side effects seen in clinical trials. The most common side effects are central nervous system (CNS) symptoms and rash. Sustiva can effect your dreams, making them very vivid and some people report problems with nightmares. Others have had problems with dizziness and trouble concentrating. Most side effects last only a few weeks and might not be as much of a problem if taken right before bed. Some people get a rash, but for most it is mild and can be treated without stopping Sustiva. The rash usually appears in the first few days of beginning Sustiva. If you develop a rash call your doctor before you stop taking the medicine.



This is a Non-Profit Organization
You can follow this link to find out more on donations:

image


image
image
image image image
image image image image image image